Experiments in animals have shown that administering simvastatin immediately after the stroke can reduce spleen atrophy and splenocyte apoptosis in a mouse MCAO model, thereby inhibiting the expression of brain IFN-γ and reducing the risk of pulmonary bacterial infection (Lee et al., 2008) and proving that there is a close relationship between spleen and stroke. Here, IFNG is linked to Stroke.